Rhenman & Partners Asset Management AB as of Dec. 31, 2014
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 84 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Celgene Corporation | 5.9 | $20M | 182k | 111.86 | |
Gilead Sciences (GILD) | 5.6 | $19M | 206k | 94.26 | |
CVS Caremark Corporation (CVS) | 2.7 | $9.3M | 97k | 96.31 | |
Regeneron Pharmaceuticals (REGN) | 2.7 | $9.2M | 23k | 410.27 | |
Abbvie (ABBV) | 2.7 | $9.2M | 140k | 65.44 | |
Alkermes (ALKS) | 2.4 | $8.4M | 143k | 58.56 | |
Alexion Pharmaceuticals | 2.4 | $8.1M | 44k | 185.02 | |
Biogen Idec (BIIB) | 2.1 | $7.3M | 22k | 339.44 | |
Medivation | 2.0 | $7.0M | 71k | 99.60 | |
Actavis | 2.0 | $7.0M | 27k | 257.41 | |
Bristol Myers Squibb (BMY) | 2.0 | $6.8M | 115k | 59.03 | |
Universal Technical Institute (UTI) | 2.0 | $6.8M | 61k | 111.26 | |
UnitedHealth (UNH) | 2.0 | $6.8M | 67k | 101.09 | |
Receptos | 1.9 | $6.4M | 53k | 122.51 | |
Amgen (AMGN) | 1.8 | $6.2M | 39k | 159.29 | |
Esperion Therapeutics (ESPR) | 1.8 | $6.1M | 150k | 40.44 | |
Rite Aid Corporation | 1.7 | $5.9M | 785k | 7.52 | |
Covidien | 1.7 | $5.8M | 57k | 102.28 | |
Cardinal Health (CAH) | 1.6 | $5.7M | 70k | 80.73 | |
BioMarin Pharmaceutical (BMRN) | 1.6 | $5.5M | 61k | 90.39 | |
ACADIA Pharmaceuticals (ACAD) | 1.5 | $5.2M | 165k | 31.75 | |
Anthem (ELV) | 1.5 | $5.2M | 41k | 125.66 | |
Clovis Oncology | 1.4 | $4.8M | 85k | 56.00 | |
Catamaran | 1.4 | $4.8M | 92k | 51.75 | |
Eli Lilly & Co. (LLY) | 1.3 | $4.6M | 66k | 68.98 | |
Merck & Co (MRK) | 1.3 | $4.5M | 80k | 56.79 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $4.5M | 38k | 118.79 | |
Achillion Pharmaceuticals | 1.3 | $4.5M | 368k | 12.25 | |
Salix Pharmaceuticals | 1.3 | $4.4M | 38k | 114.95 | |
Celladon | 1.1 | $3.8M | 196k | 19.53 | |
Nektar Therapeutics (NKTR) | 1.1 | $3.7M | 238k | 15.50 | |
AmerisourceBergen (COR) | 1.1 | $3.6M | 40k | 90.15 | |
Dex (DXCM) | 1.0 | $3.5M | 64k | 55.05 | |
Community Health Systems (CYH) | 1.0 | $3.5M | 64k | 53.92 | |
Intercept Pharmaceuticals In | 1.0 | $3.4M | 22k | 156.00 | |
McKesson Corporation (MCK) | 1.0 | $3.3M | 16k | 207.56 | |
Incyte Corporation (INCY) | 0.9 | $3.2M | 44k | 73.11 | |
Celldex Therapeutics | 0.9 | $3.2M | 175k | 18.25 | |
NPS Pharmaceuticals | 0.9 | $3.2M | 89k | 35.78 | |
Thoratec Corporation | 0.9 | $3.0M | 92k | 32.46 | |
Hca Holdings (HCA) | 0.9 | $3.0M | 41k | 73.39 | |
Endologix | 0.9 | $3.0M | 194k | 15.29 | |
Centene Corporation (CNC) | 0.8 | $2.9M | 28k | 103.86 | |
Jazz Pharmaceuticals (JAZZ) | 0.8 | $2.8M | 17k | 163.74 | |
Cepheid | 0.8 | $2.8M | 52k | 54.13 | |
Intra Cellular Therapies (ITCI) | 0.8 | $2.8M | 160k | 17.65 | |
Becton, Dickinson and (BDX) | 0.8 | $2.8M | 20k | 139.16 | |
Abiomed | 0.8 | $2.8M | 73k | 38.05 | |
HeartWare International | 0.8 | $2.8M | 38k | 73.42 | |
Thermo Fisher Scientific (TMO) | 0.8 | $2.8M | 22k | 125.27 | |
Ariad Pharmaceuticals | 0.8 | $2.7M | 397k | 6.87 | |
Auxilium Pharmaceuticals note | 0.8 | $2.6M | 77k | 34.39 | |
Macrogenics (MGNX) | 0.8 | $2.6M | 75k | 35.07 | |
Array BioPharma | 0.8 | $2.6M | 545k | 4.73 | |
AmSurg | 0.8 | $2.6M | 47k | 54.72 | |
ISIS Pharmaceuticals | 0.8 | $2.6M | 42k | 61.74 | |
St. Jude Medical | 0.8 | $2.6M | 40k | 65.02 | |
Hologic (HOLX) | 0.7 | $2.5M | 94k | 26.74 | |
Medtronic | 0.7 | $2.5M | 35k | 72.20 | |
Aetna | 0.7 | $2.5M | 28k | 88.82 | |
Cerner Corporation | 0.7 | $2.5M | 38k | 64.66 | |
Edwards Lifesciences (EW) | 0.7 | $2.4M | 19k | 127.37 | |
Insulet Corporation (PODD) | 0.7 | $2.4M | 52k | 46.06 | |
Tesaro | 0.7 | $2.3M | 63k | 37.19 | |
Old Republic International Corporation (ORI) | 0.7 | $2.3M | 70k | 33.11 | |
Orexigen Therapeutics | 0.7 | $2.3M | 375k | 6.06 | |
Pharmacyclics | 0.7 | $2.3M | 19k | 122.27 | |
Tandem Diabetes Care | 0.7 | $2.3M | 179k | 12.70 | |
Cyberonics | 0.7 | $2.2M | 40k | 55.68 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $2.2M | 23k | 97.00 | |
Revance Therapeutics (RVNC) | 0.6 | $2.1M | 127k | 16.94 | |
Dynavax Technologies Corporation | 0.6 | $2.1M | 123k | 16.86 | |
Ligand Pharmaceuticals In (LGND) | 0.6 | $2.1M | 39k | 53.21 | |
Supernus Pharmaceuticals (SUPN) | 0.6 | $2.1M | 251k | 8.30 | |
Kite Pharma | 0.6 | $2.0M | 35k | 57.66 | |
Omnicare | 0.5 | $1.8M | 25k | 72.92 | |
Myriad Genetics (MYGN) | 0.5 | $1.7M | 50k | 34.06 | |
Lexicon Pharmaceuticals | 0.4 | $1.5M | 1.6M | 0.91 | |
Keryx Biopharmaceuticals | 0.4 | $1.3M | 90k | 14.14 | |
Mirati Therapeutics | 0.2 | $841k | 45k | 18.53 | |
Xencor (XNCR) | 0.2 | $802k | 50k | 16.04 | |
Bind Therapeutics | 0.2 | $721k | 134k | 5.40 | |
Threshold Pharmaceuticals | 0.2 | $641k | 202k | 3.18 | |
Anthera Pharmaceutcls | 0.2 | $632k | 400k | 1.58 |